angiostrongyliasis
ICD-10: B81.3MeSH: C536369ORPHA: 741 Treatment Available
Overview
parasitic helminthiasis infectious disease by Angiostrongylus cantonensis or Angiostrongylus costaricensis
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Nitazoxanide | Tablet, Oral suspension | FDA Approved | 1 | 5d |
Clinical Presentation
Signs and symptoms associated with angiostrongyliasis, sourced from HPO and Orphanet clinical annotations.
HeadacheCSF pleocytosisSeverely increased total eosinophil countDiplopiaIrritabilityExcessive daytime somnolenceMeningitisFeverVomitingConstipationAbdominal painIncreased intracranial pressureProjectile vomitingArthralgiaMyalgiaParesthesiaPoor appetiteUnusual CNS infectionFatigueStiff neckGastrointestinal eosinophiliaBrain imaging abnormalityBlurred visionPruritusSeizureMuscle weaknessNauseaVentriculomegalyCerebral edemaDistal muscle weaknessIncreased circulating IgG concentrationIncreased circulating IgA concentrationIncreased circulating IgM levelPainNeck painNuchal rigidityIncreased circulating specific IgE antibody concentrationComaHyperesthesia
Classification & Codes
ICD-10 Code
B81.3MeSH Code
C536369Orphanet Code
ORPHA:74angiostrongyliasis
| ICD-10 | B81.3 |
| MeSH | C536369 |
| Orphanet | ORPHA:74 |
| Treatments | 1 drug(s) |
| Symptoms on record | 39 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO